A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1997
10/23/1997	CA2251849A1 Hydrophobic carbomer complex compositions
10/23/1997	CA2251818A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997	CA2251814A1 N-aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
10/23/1997	CA2251800A1 Nitrone free radical trap treatment of dementia associated with aids virus (hiv-1) infection
10/23/1997	CA2251780A1 Methods of treating immunopathologies using polyunsaturated fatty acids
10/23/1997	CA2251733A1 Dhea combination therapy
10/23/1997	CA2251724A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
10/23/1997	CA2251716A1 Sensitization of cells to radiation and chemotherapy
10/23/1997	CA2251681A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
10/23/1997	CA2251642A1 New pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
10/23/1997	CA2251631A1 Intestinal trefoil proteins
10/23/1997	CA2251543A1 Novel cationic cholesteryl derivatives containing cyclic polar groups
10/23/1997	CA2251532A1 Immobilized alliinase and continuous production of allicin
10/23/1997	CA2251394A1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
10/23/1997	CA2251384A1 Use of alkylaryl polyether alcohol polymers for the inhibition of nuclear transcription factor nf-xb
10/23/1997	CA2251381A1 New carboxylic acid derivatives, their production and use
10/23/1997	CA2251335A1 3-[(1,2,3,4-tetrahydroisoquinoline-2-yl)methyl]-8-azabicyclo[3.2.1]octane derivatives, their preparation and their application in therapeutics
10/23/1997	CA2251292A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
10/23/1997	CA2251269A1 A method for detection of potential co-antioxidants
10/23/1997	CA2251204A1 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
10/23/1997	CA2251115A1 Novel rantes homolog from prostate
10/23/1997	CA2251092A1 D-mannitol and its preparation
10/23/1997	CA2251071A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
10/23/1997	CA2250943A1 Piperidinylpyrimidine derivatives
10/23/1997	CA2250907A1 Use of growth hormone
10/23/1997	CA2250764A1 Novel carboxylic acid derivatives, their production and use
10/23/1997	CA2250757A1 Novel .alpha.-hydroxylic acid derivatives, their production and use
10/23/1997	CA2250707A1 Cysteine-containing or methionine-containing peptides with immunomodulatory effects
10/23/1997	CA2249601A1 Inhibitors of farnesyl-protein transferase
10/23/1997	CA2241051A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/22/1997	EP0802199A2 Covalently bound dimers of glycopetide antibiotics
10/22/1997	EP0802198A2 Pyridazino-, pyrimido, pyrazino and triazino-indoles
10/22/1997	EP0802197A1 Tricyclic-heterocyclyl substituted phenylacetamide derivatives, their preparation and their use as angiostensin-II-antagonists
10/22/1997	EP0802196A1 Alkylenediamine derivative, antiulcer drug, and antibacterial drug
10/22/1997	EP0802195A2 Substituted 2,3-benzodiazepine derivatives, process and intermediates for their preparation and pharmaceutical compositions comprising them as well as their use
10/22/1997	EP0802192A1 Heterocyclic-substituted phenylglycinolamides with antiatheroschlerotic activity and process for their production
10/22/1997	EP0802188A1 Phenylglycinolamides linked by a hetero-atom with antiatherosclerotic agents
10/22/1997	EP0802186A1 Benzyloxy-substituted phenylglycinolamides as pharmaceutical agents
10/22/1997	EP0802184A1 N-Benzyl-2-phenylindoles as estrogenic agents
10/22/1997	EP0802183A1 Estrogenic agents
10/22/1997	EP0802182A1 PROCESS FOR PRODUCING N-(D-$g(a)-METHYL-$g(b)-MERCAPTOPROPIONYL)-L-PROLINE AND INTERMEDIATES THEREOF
10/22/1997	EP0802181A1 Retinoids
10/22/1997	EP0801950A1 Pharmaceutical composition for diuretic and antihypertensive oral therapy comprising furosemide and tromethamine
10/22/1997	EP0801949A1 Hypoglycemic quinone derivative
10/22/1997	EP0801948A1 Ophthalmic composition having prolonged residence time in the eye
10/22/1997	EP0801947A1 Use of octopirox as skin depigmentation agent
10/22/1997	EP0801946A2 Use of salicin as agent against irritation in cosmetic and topical dermatological compositions
10/22/1997	EP0801945A2 Use of ferulic acid glucosides as agents against irritation in cosmetic or topical dermatological compositions
10/22/1997	EP0801653A2 Tetracyclic triterpenes
10/22/1997	EP0801651A1 Hydroxymethylimidazodiazepines and their esters
10/22/1997	EP0801650A1 Fibrinogen receptor antagonists
10/22/1997	EP0801649A2 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
10/22/1997	EP0801648A1 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
10/22/1997	EP0801646A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/22/1997	EP0801644A1 Polyarylcarbamoylaza -and- carbamoylalkanedioic acids
10/22/1997	EP0801642A1 Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same
10/22/1997	EP0801640A1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
10/22/1997	EP0801572A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
10/22/1997	EP0801571A1 Soluble 2-chloro-2'-deoxyadenosine formulations
10/22/1997	EP0801570A1 Formulations and methods for reducing skin irritation
10/22/1997	EP0801569A1 Method for protecting the heart from ischemia
10/22/1997	EP0801568A1 Compounds for inhibition of ceramide-mediated signal transduction
10/22/1997	EP0801567A1 1,3,3-(trisubstituted)cyclohex-1-ene monomers and related compounds
10/22/1997	EP0801566A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
10/22/1997	EP0801565A1 Method and compositions for topical application of tocotrienol to the skin
10/22/1997	EP0801564A1 Use of nebivolol as an anti-atherogenic
10/22/1997	EP0801563A1 The use of 2,3-alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
10/22/1997	EP0801562A1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides
10/22/1997	EP0801561A2 Composition and methods for transdermal delivery of acid-labile drugs
10/22/1997	EP0801559A1 ORAL DOSAGE-FORMS CONTAINING A $g(b)-LACTAM ANTIBIOTIC
10/22/1997	EP0801557A2 LIPOSOME FORMULATIONS OF 5$g(b) STEROIDS
10/22/1997	EP0801554A1 Formulations and methods for reducing skin irritation
10/22/1997	EP0801527A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/22/1997	EP0748387B1 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of streptomyces sp. p 6621 ferm p 2804
10/22/1997	EP0697858B1 Nasal drug delivery composition containing nicotine
10/22/1997	EP0684948B1 Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same
10/22/1997	EP0681583B1 Tricyclic heterocyclic compounds as 5-ht4 receptor antagonists
10/22/1997	EP0660819B1 New n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds
10/22/1997	EP0646586B1 2-aminoethanesulfonic acid/zinc complex compound
10/22/1997	EP0640080B1 Substituted indoles as angiotensin ii antagonists
10/22/1997	EP0611374B1 17-beta-substituted 4-aza-5-alpha-androstan-3-one derivatives
10/22/1997	EP0543949B1 Enzymic alteration of hair growth
10/22/1997	CN1162961A Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
10/22/1997	CN1162958A Thienopyridine or thienopyrimidine derivatives and their use
10/22/1997	CN1162957A Isoxazoles
10/22/1997	CN1162919A Combination preparation, containing cyclosporin a or FK506 or rapamycin and a xanthine derivative
10/22/1997	CN1162918A Depressant of functions developed by molecule
10/22/1997	CN1162904A Eleutherobin and analogs thereof
10/22/1997	CN1162599A Process for manufacture of imidazodiazepine derivatives
10/22/1997	CN1162592A Cancer eliminating composition and preparation thereof
10/22/1997	CN1162485A Medicine for curing bilestone and biliary calculus
10/22/1997	CN1162484A Compounded Chuanlin Dingchuan capsule for asthma
10/22/1997	CN1162482A Compounded Chinese medical cream for curing scars
10/22/1997	CN1162481A External use cream for skin pigmentation
10/22/1997	CN1162467A External use medicine for curing scars
10/22/1997	CN1162447A Preparation for central nerves of muscle
10/22/1997	CN1036200C Preparation of A-norsteroid-3-carboxylic
10/22/1997	CN1036199C Erythromycin derivatives
10/22/1997	CN1036197C 水溶性喜树碱衍生物 Water-soluble derivative of camptothecin
10/22/1997	CN1036196C 1,3-Oxatholane nucleoside analogues

1 ... 6734 6735 6736 6737 6738 6739 6740 6741 6742 6743 6744 6745 6746 6747 6748 6749 6750 6751 6752 6753 6754 ... 7860